| Literature DB >> 35981767 |
Harald Walach1,2, Michael Ofner3,4, Viviane Ruof2, Markus Herbig5, Rainer Johannes Klement6.
Abstract
OBJECTIVE: To answer the question: Why do people consent to being vaccinated with novel vaccines against SARS-CoV-2?Entities:
Keywords: COVID-19; health policy; immunology; public health
Mesh:
Substances:
Year: 2022 PMID: 35981767 PMCID: PMC9393854 DOI: 10.1136/bmjopen-2021-060555
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
The Corona Orthodoxy Score—items and scaling
| Item | Scaling | Action |
| 1. SarsCov2 is less infectious (1), equally (2), more infectious (3), much more infectious (4) than seasonal influenza | 1–4 | Use score |
| 2. Infection fatality rate is lower than influenza (1), equal (2), higher (3), much higher (4) | 1–4 | Add score to sum |
| 3. The challenge to the health system with COVID-19 is less (1), equal (2), higher (3), much higher (4) than with influenza | 1–4 | Add score to sum |
| 4. Altogether, with SARS-CoV2 the immune system (0) is more important, or the virus (1)? | 0/1 | Add score to sum |
| 5. With vaccine development, one should have followed the normal sequence (2), it was good to speed up (3); no vaccines are necessary (1) | 1–3 | Add score to sum |
| 6. Altogether, more damage was done by the virus (no/yes) | 0/1 | Add score to sum |
| 7. Altogether, more damage was done by the non-pharmaceutical Interventions (no/yes) | 0/1 | Reverse code and add score to sum |
Sociodemographic description of the survey sample
| Variable | Unit | Overall cohort (n=1'032) | Vaccinated (n=855) | Unvaccinated, not wanting to become vaccinated (n=129) | Unvaccinated, intending to become vaccinated (n=48) | P value |
| Age | Years: median (range) | 52 (16–88) | 54 (16–88) | 50 (16–78) | 39 (17–74) | <0.0001* |
| Years: mean±SD | 49.6±17.8 | 50.6±17.7 | 45.6±18.1 | 41.3±16.3 | ||
| Gender | Male | 512 (49.6%) | 432 (50.5%) | 57 (44.2%) | 23 (47.9%) | 0.6 |
| Female | 517 (50.1%) | 420 (49.3%) | 72 (55.8%) | 25 (52.1%) | ||
| Diverse | 3 (0.3%) | 3 (0.3%) | 0 | 0 | ||
| Education | In training | 11 (1.1%) | 8 (0.9%) | 2 (1.55%) | 1 (2.1%) | 0.577 |
| No school leaving certificate | 6 (0.6%) | 4 (0.5%) | 2 (1.55%) | 0 | ||
| Basic schooling | 223 (21.6%) | 186 (21.8%) | 28 (21.7%) | 9 (18.8%) | ||
| GCSE | 375 (36.6%) | 310 (36.3%) | 50 (38.8%) | 15 (31.3%) | ||
| A-level | 188 (18.2%) | 150 (17.5%) | 25 (19.4%) | 13 (27.1%) | ||
| University degree | 213 (20.6%) | 183 (21.4%) | 20 (15.5%) | 10 (20.8%) | ||
| PhD | 16 (1.6%) | 14 (1.6%) | 2 (1.55%) | 0 | ||
| Income strata | <€1300 | 145 (14.0%) | 112 (13.1%) | 23 (17.8%) | 10 (20.8%) | 0.084 |
| €1300–€2000 | 183 (17.7%) | 147 (17.2%) | 27 (20.9%) | 9 (18.8%) | ||
| €2001–€2600 | 171 (16.6%) | 136 (20.0%) | 24 (18.6%) | 11 (22.9%) | ||
| €2601–€3600 | 216 (20.8%) | 180 (21.1%) | 26 (20.2%) | 10 (20.8%) | ||
| €3601–€5000 | 193 (18.7%) | 175 (20.5%) | 14 (10.9%) | 4 (8.3%) | ||
| >€5000 | 124 (12.0%) | 105 (12.3%) | 15 (11.6%) | 4 (8.3%) | ||
| No of persons in household (as categorical variable) | 1 | 324 (31.4%) | 268 (31.3%) | 42 (32.6%) | 14 (29.2%) | 0.00050* |
| 2 | 351 (34.0%) | 311 (36.4%) | 34 (26.4%) | 6 (12.5%) | ||
| 3 | 191 (18.5%) | 154 (18.0%) | 27 (20.9%) | 10 (20.8%) | ||
| 4 | 121 (11.7%) | 89 (10.4%) | 19 (14.7%) | 13 (27.1%) | ||
| 5 | 29 (2.8%) | 22 (2.6%) | 3 (2.3%) | 4 (8.3%) | ||
| 6 | 13 (1.2%) | 9 (1.1%) | 3 (2.3%) | 1 (2.1%) | ||
| 7 | 3 (0.3%) | 2 (0.2%) | 1 (0.8%) | 0 | ||
| No of persons in household (as continuous variable) | Median (range) | 2 (1–7) | 2 (1–7) | 2 (1–7) | 3 (1–6) | 0.013 |
| Mean±SD | 2.3±1.2 | 2.2±1.2 | 2.4±1.3 | 2.8±1.4 |
Kruskal-Wallis test and Fisher’s exact test with simulated p values were used to test for differences among the three groups in continuous and categorical variables, respectively.
*P<0.005 (statistically significant).
GCSE, General Certificate of Secondary Education.
Reasons for vaccination—three most important reasons—frequencies (per cent)—vaccinated persons or those with intention to be vaccinated only (n=903)
| Reason | First rank | Second rank | Third rank |
| I fear the health consequences of an infection with the corona virus | 542 (60.0%) | 115 (12.7%) | 98 (10.8%) |
| I want to be able to lead a normal life | 163 (18.5%) | 266 (29.5%) | 272 (30.1%) |
| I want to contribute to eradicating the virus | 93 (10.3%) | 268 (29.7%) | 233 (25.8%) |
| I want to travel again | 71 (7.9%) | 150 (16.6%) | 143 (15.8%) |
| My social environment exerts pressure | 29 (3.2%) | 78 (8.6%) | 85 (9.4%) |
| I do it because others do it as well | 5 (0.5%) | 26 (2.9%) | 72 (8.0%) |
Reasons for not wanting to be vaccinated—three most important reasons—frequencies (per cent)—unvaccinated persons only (n=129)
| Reason | First rank | Second rank | Third rank |
| I do not want to be treated with vaccinations whose long-term effects are unknown | 52 (40.3%) | 47 (36.4%) | 13 (10.1%) |
| I am afraid of side effects | 47 (36.4%) | 43 (33.3%) | 18 (13.9%) |
| I don’t think we need a vaccination | 12 (9.3%) | 10 (7.7%) | 30 (23.2%) |
| I have received many terrible informations | 7 (5.4%) | 20 (15.5%) | 47 (36%) |
| I principally don’t do what others do | 8 (6.2%) | 6 (4.6%) | 11 (8.5%) |
| I have had COVID-19 and am immune | 3 (2.3%) | 3 (2.3%) | 10 (7.7%) |
In vaccinated only (n=855): COVID-19 positive test, potential side effects and potential improvements (yes answers only), beliefs
| Yes | No* | |
| COVID-19+ test since vaccination | 84 (9.8%) | 771 (90.2%) |
| Potential side effects… | ||
| Thrombosis or embolies | 12 (1.4%) | |
| Psychological stress | 60 (7.0%) | |
| Other problems with blood vessel | 22 (2.6%) | |
| Lack of stamina | 66 (7.7%) | |
| Immunological problems | 23 (2.7%) | |
| None of the above | 721 (84.3%) | |
| Better since vaccination because of… | ||
| Relief | 126 (14.7%) | |
| More stamina | 28 (3.3%) | |
| Other physical problems disappeared | 20 (2.3%) | |
| Better social integration | 127 (14.8%) | |
| Better immune function | 42 (4.9%) | |
| None of the above | 595 (69.6%) | |
| Vaccination protects from infecting others with COVID-19 | 608 (71.1%) | 247 (28.9%) |
| Vaccination protects oneself from contracting COVID-19 | 301 (35.2%) | 554 (64.8%) |
*Frequencies of no answers are given where forced entry avoided missing data, else only yes answers provided and the rest is due to missing data, because the answer was not forced to be either yes or no.
Opinions regarding SARS-CoV-2—items of the ‘Covid Orthodoxy Score’ (marked with asterisk; n=1'032)
| SARS-CoV-2 compared with seasonal influenza in terms of | Less | Similar | More | Much more |
| Infectivity* | 35 (3.4%) | 199 (19.3%) | 248 (24.0%) | 550 (53.3%) |
| Infection fatality rate* | 67 (6.5%) | 229 (22.2%) | 263 (25.5%) | 473 (45.8%) |
| Challenge to the health system* | 35 (3.4%) | 216 (20.9%) | 293 (28.4%) | 488 (47.3%) |
| More important is* | the immune system | the virus | ||
| 662 (64.1%) | 370 (35.8%) | |||
| Vaccine development* | Not necessary | Normal order and sequence should be kept | Expedited development necessary | |
| 64 (6.2%) | 518 (50.2%) | 450 (43.6%) | ||
| Most damage was done by# | The virus* | NPIs* | Media | Fake News |
| 479 (46.4%) | 453 (43.9%) | 298 (28.9%) | 482 (46.7%) |
#Multiple answers possible.
NPIs, non-pharmacological interventions.
My information sources during the pandemic are mainly
| Source | Yes |
| No information | 75 (7.3%) |
| Public TV and radio | 461 (44.7%) |
| Social media (Twitter, Facebook, etc) | 66 (6.4%) |
| Scientific original publications | 65 (6.3%) |
| Alternative media (Websites, Youtube, alternative newspapers on the internet) | 102 (9.9%) |
| Own analysis of publicly available data (eg, RKI, CDC, ECDC, PEI) | 79 (7.6%) |
| Traditional newspapers and magazines (eg, SZ, SZ-online, Spiegel, Spiegel-online) | 117 (11.3%) |
| Exchange with colleagues and friends | 55 (5.3%) |
| Other sources* | 12 (0.1%) |
*Mix of all of them, RKI, web.de, other news, school, mix of scientists in media and TV.
CDC, Centers for Disease Control and Prevention; ECDC, European Centre for Disease Prevention and Control; PEI, Paul Ehrlich Institut; RKI, Robert Koch Institut; SZ, Süddeutsche Zeitung; TV, television.
Optimal logistic regression models to predict vaccination outcomes
| Model | 1: Vaccination status | 2: Willingness to be vaccinated | ||||
|
|
|
|
|
| ||
| Orthodoxy Score | 0.33±0.03 |
| 1.39 (1.30 to 1.47) | 0.41±0.04 |
| 1.50 (1.40 to 1.62) |
| Income | 0.236±0.064 |
| 1,27 (1.12 to 1.44) | − | − | − |
| Alternative media use | −0.81±0.27 |
| 0.44 (0.26 to 0.75) | − | − | − |
| Scientific original publications use | −0.88±0.35 | 0.011 | 0.42 (0.21 to 0.82) | −0.60±0.37 | 0.104 | 0.55 (0.27 to 1.13) |
| Size of household | −0.193±0.085 | 0.024 | 0.82 (0.70 to 0.97) | − | − | − |
| Age (10 years) | 0.094±0.059 | 0.114 | 1.01 (1.0 to 1.02) | − | − | − |
| Public TV and radio use | 0.15±0.23 | 0.513 | 1.16 (0.74 to 1.84) | 0.51±0.26 | 0.046 | 1.67 (1.01 to 2.75) |
| AICc | 756.4 | 588.7 | ||||
| Adj. KL-R2 | 0.212 | 0.251 | ||||
| Sensitivity | 0.684 | 0.669 | ||||
| Specificity | 0.819 | 0.899 | ||||
| Accuracy | 0.752 | 0.784 | ||||
| AUC | 0.818 | 0.844 | ||||
Intercept calculated but omitted. Sensitivity and specificity are those that maximise the overall accuracy of classification.
*significant predictors.
Adj. KL-R2, adjusted Kullback-Leibler-R2; AICc, bias-corrected Akaike information criterion; AUC, area under the curve.
Figure 1Receiver-operator-characteristics curves for model 1 (predicting vaccination status) and 2 (predicting willingness to be vaccinated).
Additional exploratory logistic regression model predicting the probability that a vaccinated participant has chosen to be vaccinated for a medical reason (n=523) vs a social reason (n=332)
| Predictor | Estimate±SE | P value | OR (95% CI) |
| Orthodoxy score | 0.248±0.029 | <2×10-16 | 1.28 (1.21 to 1.35) |
| Age (10 years) | 0.181±0.044 | 4.48×10-5 | 1.20 (1.10 to 1.31) |
| Belief that vaccination protects from disease | −0.400±0.181 | 0.0274 | 0.67 (0.47 to 0.96) |
| Belief that vaccination protects against infecting others | 0.265±0.172 | 0.124 | 1.30 (0.93 to 1.83) |
| Information from exchange with friends | −0.691±0.368 | 0.0604 | 0.50 (0.24 to 1.03) |
| AICc | 1004.3 | ||
| Adj. KL-R2 | 0.126 | ||
| Sensitivity | 0.704 | ||
| Specificity | 0.651 | ||
| Accuracy | 0.677 | ||
| AUC | 0.621 | ||
Intercept calculated but omitted. Sensitivity and specificity are those that maximise the overall accuracy of classification.
Adj. KL-R2, adjusted Kullback-Leibler-R2; AICc, Akaike information criterion; AUC, area under the curve.